IFRX

#3724
InflaRx N.V. - Common Stock
2.1 5 USD
-0.02%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
2.14
2.20
Intervallo Annuale
0.80
2.94
Variazione giornaliera
-1.76%
Variazione Mensile
+27.98%
Variazione di 6 mesi
+141.57%
Variazione Annuale
+27.98%
Chiusura Precedente
2.2 3
Open
2.1 8
Minimo
2.1 4
Massimo
2.2 0
Volume
79
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
Inflarx N.V. current report, Q3 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q1 FY2026
Inflarx N.V. current report, Q1 FY2026
6-K

Inflarx N.V. current report, Q1 FY2026

Full document

Business Context and Reporting Period

This Form 6-K filing by InflaRx N.V. covers the period ending March 13, 2026. The report discloses a regulatory notice received from The Nasdaq Stock Market LLC regarding the Company's compliance with listing standards.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate governance and listing status matter rather than financial performance data.

Material Changes

The primary material event is the receipt of a written notice from Nasdaq dated March 11, 2026. The notice indicates that for the last 30 consecutive business days, the bid price for InflaRx N.V.'s ordinary shares closed below the minimum $1.00 per share requirement under Nasdaq Listing Rule 5450(a)(1).

Outlook, Risks, and Management Commentary

  • Compliance Timeline: The Company has an initial 180-calendar-day period, until September 7, 2026, to regain compliance with the Minimum Bid Price Rule.
  • Contingency Plan: If compliance is not achieved by the initial deadline, the Company may consider transferring its securities from The Nasdaq Global Select Market to The Nasdaq Capital Market. This transfer, if approved, would provide an additional 180 days (until March 8, 2027) to regain compliance.
  • Uncertainties: There is no assurance that the Company will be eligible for the additional compliance period or that Nasdaq staff will grant the request for continued listing.
  • Immediate Impact: The notice has no immediate effect on the listing or trading of the Company's ordinary shares.
  • Management Action: The Company intends to monitor the bid price and consider available options to regain compliance.

Investor Verification Checklist

  • Verify the current trading price of InflaRx N.V. shares to assess the severity of the deviation from the $1.00 threshold.
  • Monitor the Company's progress toward regaining compliance before the September 7, 2026 deadline.
  • Review future filings for any announcement regarding a potential transfer to The Nasdaq Capital Market.
  • Check for any subsequent press releases detailing specific strategies (e.g., reverse stock splits) to address the bid price deficiency.

Notizie